ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print June 18, 2009, 10.1183/09031936.00197008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME questions
Right arrow All Versions of this Article:
34/4/932    most recent
09031936.00197008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Singanayagam, A.
Right arrow Articles by Hill, A. T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singanayagam, A.
Right arrow Articles by Hill, A. T.
Eur Respir J 2009; 34:932-939
Copyright ©ERS Journals Ltd 2009

Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia

A. Singanayagam, J. D. Chalmers and A. T. Hill

Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK.

CORRESPONDENCE: A. Singanayagam, Dept of Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh, EH16 4SA, UK. E-mail: aransinga{at}gmail.com

Keywords: Community-acquired pneumonia, hypoglycaemia, outcome

Received: December 29, 2008
Accepted June 4, 2009

The aim of our study was to investigate if hypoglycaemia correlates with outcome in community-acquired pneumonia (CAP).

We performed a prospective, observational study of consecutive patients presenting with a primary diagnosis of CAP in Lothian (UK). Admission plasma glucose was measured and, on this basis, patients were divided into two groups, hypoglycaemic (<4.4 mmol·L–1 or <79.0 mg·dL–1) and nonhypoglycaemic (≥4.4 mmol·L–1 or ≥79.0 mg·dL–1). Outcomes of interest were 30-day mortality, need for mechanical ventilation and inotropic support. Multivariable logistic regression was used to compare these outcomes in hypoglycaemic patients to nonhypoglycaemic patients, adjusting for diabetes mellitus, prior statin use and Pneumonia Severity Index.

In total, 1,050 patients were included in the study with 5.4% classified as hypoglycaemic. Increased rates of 30-day mortality (28.1% versus 7.5%, p<0.0001), need for mechanical ventilation (29.8% versus 6.5%, p<0.0001) and need for inotropic support (21.1% versus 4.8%, p<0.0001) were observed in hypoglycaemic patients compared with nonhypoglycaemic patients. On multivariable analysis, hypoglycaemia was independently associated with increased 30-day mortality (OR 2.25, 95% CI 1.1–4.7; p = 0.03), need for mechanical ventilation (OR 3.8, 95% CI 1.9–7.5; p = 0.0002) and need for inotropic support (OR, 2.9, 95% CI 1.4–6.3; p = 0.0006).

Admission hypoglycaemia is associated with increased 30-day mortality, need for mechanical ventilation and inotropic support in patients presenting with CAP.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.